Company intelligence / Profile preview

Keystone Capital

New York City, New York, United States

Ownership: Private
Development stage: Other

Overview

Keystone Capital Partners is an investment firm (family office) that invests in and finances promising micro-, small-, and mid-cap public and private companies in biotech and medical devices. Notable investments include clinical-stage antibody therapy, tissue engineering, and diagnostics companies. The firm itself is an investor, not an operating biotech/drug developer.

Therapeutic areas: GastroenterologyNeurologyOtherDermatologyOncology
Modalities: AntibodySmall molecule inhibitorMolecular diagnosticsRegenerative tissue/biomaterials
Industry: Investors

Partnerships

Novatio Solutions (hyperautomation in life science business ops)

Beyond the preview

Go deeper on Keystone Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keystone Capital.

Explore the full profile